AbbVie is a leading global biopharmaceutical company founded in 2013 after its separation from Abbott Laboratories. The company focuses on discovering, developing, and delivering innovative medicines that address some of the most complex and serious health conditions. AbbVie is well known for its treatments in areas such as immunology, oncology, neuroscience, eye care, and virology. With a strong commitment to research and development, it invests heavily in advancing new therapies to improve patient outcomes worldwide. Headquartered in North Chicago, Illinois, AbbVie operates in more than 70 countries and continues to build a strong portfolio of life-changing medicines that support millions of patients across the globe.